BioAffinity Technologies (NASDAQ:BIAFW) Shares Down 3%
BioAffinity Technologies (NASDAQ:BIAFW) Shares Down 3%
bioAffinity Technologies, Inc. (NASDAQ:BIAFW – Get Rating)'s share price traded down 3% during mid-day trading on Friday . The company traded as low as $0.33 and last traded at $0.33. 101 shares traded hands during mid-day trading, a decline of 98% from the average session volume of 5,555 shares. The stock had previously closed at $0.34.
bioAffinity Technologies Trading Down 3.0 %
The business's 50 day simple moving average is $0.41.
Get bioAffinity Technologies alerts:Institutional Inflows and Outflows
A hedge fund recently bought a new stake in bioAffinity Technologies stock. Armistice Capital LLC bought a new stake in bioAffinity Technologies, Inc. (NASDAQ:BIAFW – Get Rating) in the 3rd quarter, according to its most recent disclosure with the SEC. The fund bought 204,082 shares of the company's stock, valued at approximately $72,000.
About bioAffinity Technologies
(Get Rating)
bioAffinity Technologies, Inc, a biotechnology company, engages in developing non-invasive diagnostic tests and targeted cancer therapeutics. The company offers CyPath lung, a diagnostic test, for early detection of lung cancer. It also researches targeted therapies to treat cancer at the cellular level.
Further Reading
- Get a free copy of the StockNews.com research report on bioAffinity Technologies (BIAFW)
- Carvana Skidding On Revenue Decrease, Heavy Debt Burden
- What Are Consumer Staples Stocks?
- Is Rocky Brands Dividend A Good Fit For Your Portfolio?
- Beyond Meat Stock Is Not Beyond Hope
- Analysts Holding As Pfizer Waits On Two Phase 3 Studies
Receive News & Ratings for bioAffinity Technologies Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for bioAffinity Technologies and related companies with MarketBeat.com's FREE daily email newsletter.
bioAffinity Technologies, Inc. (NASDAQ:BIAFW – Get Rating)'s share price traded down 3% during mid-day trading on Friday . The company traded as low as $0.33 and last traded at $0.33. 101 shares traded hands during mid-day trading, a decline of 98% from the average session volume of 5,555 shares. The stock had previously closed at $0.34.
生物親和科技股份有限公司(NASDAQ:BIAFW — 獲取評級)的股價在周五中間交易期間下跌了 3%。該公司的交易價格低至 0.33 美元,最後交易價為 0.33 美元。中間交易期間 101 股,較 5,555 股的平均交易量下跌 98%。該股票之前已收盤 0.34 美元。
bioAffinity Technologies Trading Down 3.0 %
生物親和技術交易下跌 3.0%
The business's 50 day simple moving average is $0.41.
該企業的 50 天簡單移動平均線為 0.41 美元。
Institutional Inflows and Outflows
機構流入和流出
A hedge fund recently bought a new stake in bioAffinity Technologies stock. Armistice Capital LLC bought a new stake in bioAffinity Technologies, Inc. (NASDAQ:BIAFW – Get Rating) in the 3rd quarter, according to its most recent disclosure with the SEC. The fund bought 204,082 shares of the company's stock, valued at approximately $72,000.
對沖基金最近購買了生物親和科技股票的新股份。根據其最近與美國證券交易委員會的披露,停戰資本有限責任公司在第三季度收購了生物親和技術公司(NASDAQ:BIAFW-獲得評級)的新股份。該基金買入了該公司股票的 204,082 股,價值約為 72,000 美元。
About bioAffinity Technologies
關於生物親和技術
(Get Rating)
(取得評分)
bioAffinity Technologies, Inc, a biotechnology company, engages in developing non-invasive diagnostic tests and targeted cancer therapeutics. The company offers CyPath lung, a diagnostic test, for early detection of lung cancer. It also researches targeted therapies to treat cancer at the cellular level.
BioAffinity 科技有限公司是一家生物技術公司,致力於開發非侵入性診斷測試和靶向癌症治療。該公司提供 CypAth 肺部診斷 test,用於及早發現肺癌。它還研究標靶療法以治療細胞水平的癌症。
Further Reading
進一步閱讀
- Get a free copy of the StockNews.com research report on bioAffinity Technologies (BIAFW)
- Carvana Skidding On Revenue Decrease, Heavy Debt Burden
- What Are Consumer Staples Stocks?
- Is Rocky Brands Dividend A Good Fit For Your Portfolio?
- Beyond Meat Stock Is Not Beyond Hope
- Analysts Holding As Pfizer Waits On Two Phase 3 Studies
- 獲取有關生物親和技術(BIAFW)的免費研究報告
- 減少收入減少,沉重的債務負擔
- 什麼是必需消費股?
- Rocky 品牌股息是否適合您的投資組合?
- 超越肉湯不是超越希望
- 作為輝瑞公司等待兩個階段 3 研究的分析師
Receive News & Ratings for bioAffinity Technologies Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for bioAffinity Technologies and related companies with MarketBeat.com's FREE daily email newsletter.
每日接收生物親和技術的新聞和評分 -在下面輸入您的電子郵件地址,以通過 MarketBeat.com 的免費每日電子郵件通訊接收 BioAffinity 技術和相關公司的最新新聞和分析師評級的簡要每日摘要。
譯文內容由第三人軟體翻譯。
風險及免責聲明
- 分享到weixin
- 分享到qq
- 分享到facebook
- 分享到twitter
- 分享到微博
- 粘贴板
使用瀏覽器的分享功能,分享給你的好友吧